GNFT

Genfit (GNFT)

Genfit SA

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GNFT

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/30	05 : 10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNFT	Genfit SA
2024/05/23	01 : 06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNFT	Genfit SA
2024/05/15	05 : 10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNFT	Genfit SA
2024/01/17	20 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNFT	Genfit SA
2024/01/12	06 : 10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNFT	Genfit SA
2023/11/17	06 : 10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNFT	Genfit SA
2023/11/10	06 : 10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNFT	Genfit SA
2023/11/06	21 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNFT	Genfit SA
2023/09/06	05 : 10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNFT	Genfit SA
2023/07/13	05 : 10	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:GNFT	Genfit SA
2023/06/01	05 : 44	PR Newswire (US)	Seal Rock Therapeutics Announces Out-Licensing Agreement with GENFIT for Development of Injectable Formulation of SRT-015 for Acute-on-Chronic Liver Disease (ACLF)	NASDAQ:GNFT	Genfit SA
2023/06/01	05 : 16	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
2023/05/25	04 : 00	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
2023/05/12	05 : 11	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
2023/05/10	05 : 11	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
2023/05/05	19 : 07	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:GNFT	Genfit SA
2023/05/02	05 : 01	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:GNFT	Genfit SA
2023/04/28	19 : 17	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
2023/04/19	02 : 58	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:GNFT	Genfit SA
2023/01/06	06 : 11	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
2022/11/18	06 : 10	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
2022/11/11	06 : 11	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
2022/10/26	05 : 11	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
2022/09/30	05 : 11	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
2022/09/29	21 : 35	TipRanks	H.C. Wainwright Sticks to Their Buy Rating for Genfit SA (GNFT)	NASDAQ:GNFT	Genfit SA
2022/09/19	19 : 11	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
2022/07/09	05 : 16	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
2022/05/26	05 : 12	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
2022/04/30	05 : 26	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA
2022/04/27	22 : 44	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:GNFT	Genfit SA